| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NUCLEIC ACIDS RESEARCH LetPub Score 9.1
50 ratings
Rate
Reputation 9.2 Influence 9.1 Speed 9.3 | ||||||||||||||||
| 期刊簡稱 | NUCLEIC ACIDS RES | ||||||||||||||||
| ISSN | 0305-1048 | ||||||||||||||||
| E-ISSN | 1362-4962 | ||||||||||||||||
| h-index | 452 | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| 自引率 (2023-2024) | 4.80%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | https://academic.oup.com/nar | ||||||||||||||||
| 在線稿件提交 | http://mc.manuscriptcentral.com/nar | ||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||
| 出版商 | Oxford University Press | ||||||||||||||||
| 主題領域 | 生物 | ||||||||||||||||
| 出版國/地區 | ENGLAND | ||||||||||||||||
| 發行頻率 | 月2回刊行 | ||||||||||||||||
| 創刊年 | 0 | ||||||||||||||||
| 每年文章數 | 1242每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 98.94% | ||||||||||||||||
OA Related Info![]() | APC: Yes( USD3802; ) APC waiver:Check Notes Other charges: No Keywords: dna、biochemistry、computational biology、genomics、molecular biology、rna Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0305-1048%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 3.0 month(s) | ||||||||||||||||
| 競爭力 * | 來自作者的數據: About 43.75% | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
|
|
| |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
| [NUCLEIC ACIDS RESEARCH] 的評論 | 撰寫評論 |
| 作者: 巴蜀小蕾 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-08 15:56:20 評論於 I am also the second type. Did you win in the end? |
| 作者: yangmeiymmy 領域: 生物学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-08-29 08:50:41 評論於 Applying for a postdoctoral position in the United States, is it possible to work with Dr. Nar? |
| 作者: 茜54655 領域: 生物学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-07-18 08:23:07 評論於 Unlike downstairs, both my American academic boss and the Nobel laureates I know highly regard NAR. The classic articles of a certain Nobel laureate in recent years are all published in NAR (I don't need to mention their name, I think everyone can guess). Who studying nucleic acids wouldn't want to publish in NAR, apart from just riding on the hot topics like the Nature series? Of course, every top-tier journal inevitably has some average quality articles. This is unavoidable. How many questionable articles are there in Nature? I estimate there are far more than in NAR. |
| 作者: 茜54655 領域: 生物学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-07-18 08:19:35 評論於 I feel like your postdoc boss is taking advantage of you. Let's forget about PLOS Bio/Gen, but you even mentioned NC. Who doesn't know that NC is the most serious forum for spamming? Read the articles published in NAR first before commenting. |
| 作者: xibing 領域: 生物学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2023-07-05 18:53:59 評論於 How should I put it, there are still many average articles on NAR. Based on personal experience, even the postdoctoral advisor thinks that there are a lot of watered-down articles on there in the past two years. It's better to submit to NC, Development, or PLOS Bio/Gen. |
| 作者: 西域泽宇 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-09 23:15:11 評論於 in editorial review: 21 days, after in peer-review |
| 作者: 梓宸公子 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-07 10:33:50 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Experience sharing: 05-Sep-2022 First round of review submitted 27-Sep-2022 Major revision comments received 27-Feb-2023 Second round of review submitted 13-Apr-2023 Minor revision comments received 04-May-2023 Third round of review submitted 25-May-2023 Third round of comments received 25-May-2023 Minor revisions for written issues 27-May-2023 Overall, it was not easy to submit, with high requirements. Many experiments were added, but after receiving positive feedback after the major revisions, subsequent rounds were much simpler. The key is in the situation after the first round of revisions |
| 作者: 北岳康震 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-06 19:25:32 評論於 What happened afterwards? |
| 作者: 西域泽宇 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-26 20:26:22 評論於 It has been 10 days for me too |
| 作者: David zhou 領域: 生物学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-02-04 16:37:05 評論於 Doctor for five years plus two years of postdoctoral work, the biggest job was submitting to NAR. Two days later, it was sent for review. The first review took 22 days. It was rejected. Later, it was successfully published in a smaller journal, NC. NAR is highly specialized. When going to the United States to find a postdoctoral position, having a publication in NAR is much stronger than having one in NC. |
| 作者: 全式金 領域: 生物学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-02-04 16:15:54 評論於 Submit to Cell for review, but the reviewer rejected it. They suggested submitting to NAR instead. In the end, it was published in Cell Research. Although it wasn't submitted to Cell, it shows that the reviewers at Cell still recognize the value of NAR. |
| 作者: 无妄云超 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-18 20:57:46 評論於 One month after the second trial |
| 作者: 慧娜 領域: 环境科学与生态学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-01-16 15:10:24 評論於 Interdisciplinary field of environment and plant biology. An article on non-coding RNA influencing photosynthesis was rejected after major revisions by Nature plants. After over a year of additional experiments, it was instantly rejected when submitted to NAR. It's truly difficult! Submitted on January 7, 2023. Received rejection letter on January 9, 2023. |
| 作者: 慧娜 領域: 环境科学与生态学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-01-16 15:07:35 評論於 pp, pj, np, and NAR do have intersection. For example, those who study the environment will also pay attention to NAR and journals on botany. To be honest, pp, pj, and np are all second-rate journals compared to NAR. |
| 作者: 猫巷少女逸雅 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-16 09:19:03 評論於 In general, JCR is more meaningful. But if you are worried, then submit to another first-tier journal. When submitting articles, it's not guaranteed to be accepted. If your submission to a first-tier journal is not accepted, you can submit elsewhere. The key is still the quality of the work; if the quality is not good enough, it's not that we choose the articles, but the articles choose us |
| 作者: KKK 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-13 11:57:53 評論於 Comparing the pp, pj, and np in the field of botany with the NAR, aren't you mixing up things that are unrelated? |
| 作者: 黑山素英 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-11 19:46:08 評論於 Is it still possible to invest after the second round? |
| 作者: qiohfdl 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-05 14:08:54 評論於 Although I know that there are many Chinese people around me who value the influence of NAR and specifically access the water database, this one is definitely a top-tier journal in the field of nucleic acid research. It should have no problem competing with smaller journals. The classification of the Chinese Academy of Sciences is becoming increasingly unprofessional, with a bunch of mediocre journals and domestically produced journals being classified as first-tier journals. Well-known journals with good reputation are being classified into the second, third, and fourth tiers. Is it because ZZ is correct? |
| 作者: 无妄云超 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-04 22:18:32 評論於 I am also quite miserable. The MC is being overhauled, the boss is anxious to send it back, not enough repairs, the second review is doomed |
| 作者: linxiaopitt 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-12-27 01:41:45 評論於 What was said downstairs is correct. When looking for junior teaching positions in the United States, NAR is more useful than NC. NAR has been publishing for a long time and has a good reputation in the field of nucleic acids. There are basically no spam articles related to microRNA/Non-long coding, and the editors also have strict quality control. I don't know why the Chinese Academy of Sciences classified it as a second-tier journal. Even if it's not as good, it's still better than journals like Cell Death and Disease. CDD is already classified as a first-tier journal. Just take a look on PubPeer, and you will find plenty of articles with image misuse on CDD. |
| 作者: Yousi 領域: 生物学 審稿時間: 5.0 month(s) 結果: 拒稿 撰寫評論 |
2022-12-25 09:46:43 評論於 Congratulations to the Chinese Academy of Sciences for successfully shaming the US! |
| 作者: Yousi 領域: 生物学 審稿時間: 5.0 month(s) 結果: 拒稿 撰寫評論 |
2022-12-25 09:45:24 評論於 Um.............. A senior fellow used two articles from NAR (Nucleic Acids Research) and several small articles to find a teaching position at a state university ranked around 50 in the United States last year. It turns out that in the US, having two articles in a second-tier journal is enough to find a teaching position. By the way, from my observation, NAR is at least more effective than Nature Communications for finding teaching positions in the United States. |
| 作者: Jasonwoon 領域: 生物学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-12-23 14:54:48 評論於 It seems that everyone's anger is unanimous! The boss of the postdoctoral position is a NAS member. I originally planned to publish a small insignificant article last year, but the boss said I should choose a widely recognized journal in the field, such as NAR, to establish my own reputation. The boss may feel that the insignificant article is too populist and lacks prestige. So I submitted to NAR and it was accepted. The entire submission process went smoothly, and the additional experiments were ones we had thought of before but hadn't done due to a sense of luck. I feel that the boss is right, after all, I also don't think much of the insignificant article. However, after returning to China for more than half a year, I deeply feel the erosion of NPG on the Chinese scientific research community. Even NC is considered a sub-journal of high-level specialized journals. Chaos is rampant! |
| 作者: 林夕 領域: 生物学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2022-12-23 14:39:17 評論於 Agreed, our lab boss said the new partition has made everyone extremely angry, forcing us to waste time. |
| 作者: 林夕 領域: 生物学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2022-12-23 14:36:59 評論於 You're right, there are very few citations in NAR's articles. The NAR articles from the dual academic team at MAPS, with whom I collaborated, are also rarely cited. The only reason for this is that their articles may be unreadable to most researchers, including you. Truly innovative articles do not have high citation rates. High citation rates are found in articles on hot topics such as graphene, gene editing, and global warming. However, these hot topic articles have little scientific value in terms of advancement. |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
Contact us